Literature DB >> 9279377

Transcription of adenovirus type 2 genes in a cell-free system: apparent heterogeneity of initiation at some promoters.

D C Lee1, R G Roeder.   

Abstract

We examined the transcription of a variety of adenovirus type 2 genes in a cell-free system containing purified ribonucleic acid polymerase II and a crude extract from cultured human cells. The early EIA, EIB, EIII, and EIV genes and the intermediate polypeptide IX gene, all of which contain a recognizable TATAA sequence upstream from the cap site, were actively transcribed in vitro, albeit with apparently different efficiencies, whereas the early EII (map position 74.9) and IVa2 genes, both of which lack a TATAA sequence, were not actively transcribed. A reverse transcriptase-primer extension analysis showed that the 5' ends of the in vitro transcripts were identical to those of the corresponding in vivo ribonucleic acids and that, in those instances where initiation was heterogeneous in vivo, a similar kind of heterogeneity was observed in the cell-free system. Transcription of the polypeptide IX gene indicated that this transcript was not terminated at, or processed to, the polyadenylic acid addition site in vitro. We also failed to observe, using the in vitro system, any indication of transcriptional regulation based on the use of adenovirus type 2-infected cell extracts.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 9279377      PMCID: PMC369711          DOI: 10.1128/mcb.1.7.635-651.1981

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

Review 1.  Structure and in vitro transcription of human globin genes.

Authors:  N J Proudfoot; M H Shander; J L Manley; M L Gefter; T Maniatis
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

Review 2.  Transcription and RNA processing by the DNA tumour viruses.

Authors:  E B Ziff
Journal:  Nature       Date:  1980-10-09       Impact factor: 49.962

3.  Definition of a novel promoter for the major adenovirus-associated virus mRNA.

Authors:  M R Green; R G Roeder
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

4.  Mapping of the 3' terminus of the large late ad-2 transcript by electron microscopy.

Authors:  N W Fraser; M T Hsu
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

5.  The beta major and beta minor globin nuclear transcripts of Friend erythroleukemia cells induced to differentiate in culture.

Authors:  P Curtis; A C Finnigan; G Rovera
Journal:  J Biol Chem       Date:  1980-10-10       Impact factor: 5.157

6.  Accurate transcription initiation on a purified mouse beta-globin DNA fragment in a cell-free system.

Authors:  D S Luse; R G Roeder
Journal:  Cell       Date:  1980-07       Impact factor: 41.582

7.  Specific in vitro initiation of transcription on conalbumin and ovalbumin genes and comparison with adenovirus-2 early and late genes.

Authors:  B Wasylyk; C Kédinger; J Corden; O Brison; P Chambon
Journal:  Nature       Date:  1980-06-05       Impact factor: 49.962

8.  Control of adenovirus early gene expression: a class of immediate early products.

Authors:  J B Lewis; M B Mathews
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

9.  The gene for polypeptide IX of adenovirus type 2 and its unspliced messenger RNA.

Authors:  P Aleström; G Akusjärvi; M Perricaudet; M B Mathews; D F Klessig; U Pettersson
Journal:  Cell       Date:  1980-03       Impact factor: 41.582

10.  Regulation of early adenovirus transcription: a protein product of early region 2 specifically represses region 4 transcription.

Authors:  J R Nevins; J J Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

View more
  27 in total

1.  Proline biosynthesis in Saccharomyces cerevisiae: analysis of the PRO3 gene, which encodes delta 1-pyrroline-5-carboxylate reductase.

Authors:  M C Brandriss; D A Falvey
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

Review 2.  Promoting developmental transcription.

Authors:  Uwe Ohler; David A Wassarman
Journal:  Development       Date:  2010-01       Impact factor: 6.868

3.  Identification of two transcription factors that bind to specific elements in the promoter of the adenovirus early-region 4.

Authors:  H Watanabe; T Imai; P A Sharp; H Handa
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

4.  DNA sequences required for specific and efficient initiation of transcription at the polyoma virus early promoter.

Authors:  P Jat; U Novak; A Cowie; C Tyndall; R Kamen
Journal:  Mol Cell Biol       Date:  1982-07       Impact factor: 4.272

5.  The requirement for the A block promoter element in tRNA gene transcription in vitro depends on the ionic environment.

Authors:  O S Gabrielsen; T B Oyen
Journal:  Nucleic Acids Res       Date:  1987-07-24       Impact factor: 16.971

6.  Transcription of adenovirus cores in vitro: major RNA products differ from those made from a DNA template.

Authors:  E Daniell; M J Fedor
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Regulation of in vitro and in vivo transcription of early-region IV of adenovirus type 5 by multiple cis-acting elements.

Authors:  S Hanaka; T Nishigaki; P A Sharp; H Handa
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

8.  Developmental regulation of DNase I-hypersensitive sites in Dictyostelium discoideum.

Authors:  K Ayres; W Neuman; W G Rowekamp; S Chung
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Factors involved in specific transcription by mammalian RNA polymerase II: purification, genetic specificity, and TATA box-promoter interactions of TFIID.

Authors:  N Nakajima; M Horikoshi; R G Roeder
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.